U.S. Physical Therapy, Inc. USPH
$83.08
-$0.31-0.37%
NYSE
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 11.76% | 13.83% | 16.10% | 16.39% | 14.31% |
| Total Other Revenue | 9.47% | 13.49% | 17.84% | 23.27% | 26.67% |
| Total Revenue | 11.36% | 13.77% | 16.39% | 17.51% | 16.25% |
| Cost of Revenue | 12.21% | 13.57% | 16.23% | 20.68% | 18.12% |
| Gross Profit | 8.38% | 14.50% | 16.95% | 7.48% | 10.12% |
| SG&A Expenses | 13.96% | 17.37% | 18.24% | 17.22% | 16.68% |
| Depreciation & Amortization | 0.43% | 8.47% | 17.85% | -18.31% | -9.41% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.00% | 13.78% | 16.48% | 18.46% | 16.83% |
| Operating Income | 5.89% | 13.71% | 15.64% | 9.68% | 11.54% |
| Income Before Tax | -4.52% | 13.17% | 29.24% | 93.31% | 55.47% |
| Income Tax Expenses | 2.31% | 19.73% | 35.59% | 95.03% | 53.69% |
| Earnings from Continuing Operations | -6.71% | 11.05% | 27.20% | 92.76% | 56.05% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -15.36% | -26.79% | -29.95% | -85.47% | -73.89% |
| Net Income | -15.56% | 4.34% | 25.96% | 95.63% | 49.89% |
| EBIT | 5.89% | 13.71% | 15.64% | 9.68% | 11.54% |
| EBITDA | 4.98% | 12.90% | 16.53% | 15.08% | 15.57% |
| EPS Basic | -92.31% | -76.85% | -22.76% | 154.24% | 116.55% |
| Normalized Basic EPS | -4.59% | -0.76% | -4.72% | -27.36% | -19.74% |
| EPS Diluted | -92.31% | -76.85% | -22.76% | 154.24% | 116.55% |
| Normalized Diluted EPS | -4.59% | -0.76% | -4.72% | -27.36% | -19.74% |
| Average Basic Shares Outstanding | 0.19% | 0.60% | 0.74% | 0.78% | 0.72% |
| Average Diluted Shares Outstanding | 0.19% | 0.60% | 0.74% | 0.78% | 0.72% |
| Dividend Per Share | 2.25% | 2.26% | 2.27% | 2.29% | 2.30% |
| Payout Ratio | 0.21% | -0.01% | -0.18% | -0.47% | -0.31% |